Home
>
National Drug Code (NDC)
>
Helixate FS
Helixate FS - 0053-8135-02 - (Antihemophilic Factor, Recombinant)
Drug Information of Helixate FS
| Product NDC: | 0053-8135 |
| Proprietary Name: | Helixate FS |
| Non Proprietary Name: | Antihemophilic Factor, Recombinant |
| Active Ingredient(s): | & nbsp; Antihemophilic Factor, Recombinant |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Helixate FS
| Product NDC: | 0053-8135 |
| Labeler Name: | CSL Behring LLC |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA103332 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20090731 |
Package Information of Helixate FS
| Package NDC: | 0053-8135-02 |
| Package Description: | 1 KIT in 1 BOX (0053-8135-02) * 5 mL in 1 VIAL, SINGLE-USE (0053-8145-01) * 5 mL in 1 VIAL (0053-7653-07) |
NDC Information of Helixate FS
| NDC Code | 0053-8135-02 |
| Proprietary Name | Helixate FS |
| Package Description | 1 KIT in 1 BOX (0053-8135-02) * 5 mL in 1 VIAL, SINGLE-USE (0053-8145-01) * 5 mL in 1 VIAL (0053-7653-07) |
| Product NDC | 0053-8135 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Antihemophilic Factor, Recombinant |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20090731 |
| Marketing Category Name | BLA |
| Labeler Name | CSL Behring LLC |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
